{"id":"W2015739947","doi":"10.1016/j.lungcan.2013.07.012","title":"Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/NCIC CTG BR14 trial)","year":2013,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"Kingston General Hospital","funders":"National Cancer Institute; Eli Lilly and Company","keywords":"Vinorelbine; Gemcitabine; Medicine; Cisplatin; Oncology; Lung cancer; Internal medicine; Randomized controlled trial; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006351333,0.001006041,0.005744218,0.001005041,0.0002282007,0.00007339393,0.0004385273,0.0003064641,0.00370951],"category_scores_gemma":[0.0001553723,0.0007219448,0.001329411,0.001406819,0.0003540195,0.0004032539,0.0001089942,0.0003355005,0.000008584655],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003100001,"about_ca_system_score_gemma":0.003575942,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01776998,"about_ca_topic_score_gemma":0.009690159,"domain_scores_codex":[0.994011,0.0001740538,0.002874305,0.001241513,0.0007002876,0.0009987799],"domain_scores_gemma":[0.9940423,0.0009570157,0.002373141,0.001185236,0.0009223842,0.0005198766],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.924952,0.001076879,0.0007146852,0.001317802,0.01818767,0.00001884408,0.002178513,0.04362338,0.003480971,0.00004696416,0.002943605,0.001458753],"study_design_scores_gemma":[0.7297058,0.002306351,0.0002294011,0.0006324693,0.03402539,0.000003726476,0.0003354164,0.2301152,0.001832799,0.000007112631,0.0002021805,0.0006042175],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9638137,0.003428179,0.00437041,0.0007353022,0.001175629,0.02334338,0.002203881,0.0001086698,0.0008208982],"genre_scores_gemma":[0.9646069,0.0008383359,0.003756811,0.0002006392,0.0006968885,0.01609412,0.001908709,0.0002021713,0.01169544],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1952462,"threshold_uncertainty_score":0.9995232,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01454236991055948,"score_gpt":0.3409980195533927,"score_spread":0.3264556496428332,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}